Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand.

Butsabong Lerkvaleekul,Sirirat Charuvanij,Maynart Sukharomana,Kwanchai Pirojsakul, Malisa Kamolwatwong,Soamarat Vilaiyuk

Frontiers in pediatrics（2023）

引用 0|浏览1

暂无评分

摘要

The COVID-19 vaccine is recommended for children with rheumatic disease, particularly those who are in stable condition. After COVID-19 vaccination, patients-especially those with active disease before vaccination or those receiving concurrent prednisolone doses of ≥10 mg/day-should be closely monitored.

查看译文

关键词

disease flare, SAR-CoV-2, autoimmune diseases, immunization, new-onset of rheumatic disease, juvenile idiopathic arthritis, prednisolone, connective tissue diseases

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要